Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Horizon Therapeutics USA (formerly Horizon Pharma)
Lobbying Relationship
Bills mentioned
H.R.2430: FDA Reauthorization Act of 2017
Sponsor: Greg Walden (R-Ore.)
S.932: BASIC Act
Sponsor: Steve Daines (R-Mont.)
S.1878: Voluntary Protection Program Act
Sponsor: Michael B. Enzi (R-Wyo.)
H.R.1628: American Health Care Act of 2017
Sponsor: Diane Black (R-Tenn.)
H.R.6: 21st Century Cures Act
Sponsor: Fred Upton (R-Mich.)
S.1878: Advancing Hope Act of 2016
Sponsor: Bob Casey (D-Pa.)
H.R.7667: Food and Drug Amendments of 2022
Sponsor: Anna G. Eshoo (D-Calif.)
S.4348: FDASLA Act of 2022
Sponsor: Patty Murray (D-Wash.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Paul Kim | n/a |
| Kevin Brennan | n/a |
| Isa Mirza | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate